
    
      PROTOCOL OUTLINE: This is an unblinded study. Patients start a preventive heme regimen and
      are followed for 6 months prior to tin mesoporphyrin. The frequency of attacks is recorded.

      Patients receive tin mesoporphyrin once a week for 6 months. Patients must avoid sunlight
      during treatment and for 2 months thereafter. The frequency of heme infusions is reduced by
      half and the frequency of attacks of porphyria is monitored.

      Patients are followed for 6 months after last treatment.
    
  